Fort Washington Investment Advisors Inc. OH Buys Shares of 232,470 Doximity, Inc. (NASDAQ:DOCS)

Fort Washington Investment Advisors Inc. OH bought a new stake in shares of Doximity, Inc. (NASDAQ:DOCSFree Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 232,470 shares of the company’s stock, valued at approximately $6,518,000. Fort Washington Investment Advisors Inc. OH owned approximately 0.13% of Doximity at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Pacer Advisors Inc. grew its stake in Doximity by 78.2% during the 4th quarter. Pacer Advisors Inc. now owns 25,802 shares of the company’s stock valued at $723,000 after acquiring an additional 11,324 shares in the last quarter. Raymond James Financial Services Advisors Inc. grew its stake in Doximity by 21.8% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 22,247 shares of the company’s stock valued at $624,000 after acquiring an additional 3,978 shares in the last quarter. SG Americas Securities LLC purchased a new position in Doximity during the 4th quarter valued at about $721,000. Yarbrough Capital LLC purchased a new position in Doximity during the 4th quarter valued at about $240,000. Finally, Creative Financial Designs Inc. ADV grew its stake in shares of Doximity by 16.7% in the 4th quarter. Creative Financial Designs Inc. ADV now owns 3,301 shares of the company’s stock valued at $93,000 after buying an additional 473 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently commented on DOCS shares. SVB Leerink started coverage on Doximity in a research note on Monday, February 26th. They issued a “market perform” rating and a $32.00 price target for the company. Bank of America boosted their price target on Doximity from $29.00 to $32.00 and gave the company a “neutral” rating in a research note on Tuesday, January 23rd. JPMorgan Chase & Co. boosted their price target on Doximity from $22.00 to $25.00 and gave the company an “underweight” rating in a research note on Friday, March 15th. Leerink Partnrs reissued a “market perform” rating on shares of Doximity in a research note on Monday, February 26th. Finally, Barclays started coverage on Doximity in a research note on Wednesday, January 3rd. They issued an “equal weight” rating and a $31.00 price target for the company. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $28.00.

Get Our Latest Analysis on DOCS

Doximity Stock Up 0.3 %

Shares of DOCS stock opened at $26.99 on Wednesday. Doximity, Inc. has a 12 month low of $19.71 and a 12 month high of $37.10. The firm has a market cap of $5.03 billion, a PE ratio of 40.89, a price-to-earnings-growth ratio of 3.71 and a beta of 1.18. The stock has a 50 day moving average of $28.60 and a 200-day moving average of $25.54.

Doximity (NASDAQ:DOCSGet Free Report) last issued its quarterly earnings results on Thursday, February 8th. The company reported $0.25 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.06. Doximity had a return on equity of 16.08% and a net margin of 29.39%. The company had revenue of $135.28 million during the quarter, compared to analyst estimates of $127.46 million. As a group, equities analysts predict that Doximity, Inc. will post 0.72 EPS for the current fiscal year.

Insider Activity

In other news, Director Kira Scherer Wampler sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $28.27, for a total transaction of $141,350.00. Following the sale, the director now directly owns 10,258 shares in the company, valued at $289,993.66. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 39.40% of the stock is currently owned by company insiders.

Doximity Company Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Featured Stories

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.